Weight maintenance following the STRIDE lifestyle intervention for individuals taking antipsychotic medications.

ABSTRACT:

Objective

Individuals taking antipsychotic medications have increased risk of obesity-related early morbidity/mortality. This report presents weight maintenance results from a successful weight loss and behavioral lifestyle change program developed for people taking antipsychotic medications.

Methods

STRIDE was a two-arm randomized controlled trial. Intervention participants attended weekly group meetings for 6 months, then monthly group meetings for 6 months. Assessments were completed at baseline and at 6, 12, and 24 months.

Results

At 24 months, intervention participants lost 3.7% of baseline weight and control participants 2.1%, a non-significant difference. Fasting glucose results followed a similar pattern. There was a statistically significant difference, howev

SUBMITTER: Green CA 

PROVIDER: S-EPMC4586363 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature